A A Email Print Share

Institutional Biosafety

Biosafety Policies and Procedures

All research conducted at Duquesne University involving recombinant DNA molecules must be approved by the Institutional Biosafety Committee (IBC) using the Biosafety Committee registration document. This must be done before the laboratory phase of the research begins. Questions concerning this procedure should be directed to the committee chair.

Biosafety Committee Registration Document

NIH Guidelines for Research Involving Recombinant DNA Molecules

Institutional Biosafety Committee (IBC)


All individuals who intend to acquire, transport or engage in research with CDC, USDA Select Agents and CDC Select Agents, as defined by the Center for Disease Control and Prevention (CDC) and the U.S. Department of Agriculture (USDA) are required to inform the Office of Research before work can begin. Select Agents are certain viruses, bacteria, rickettsia, fungi and toxins defined by CDC and the USDA. Research in our laboratories must adhere to CDC’s guidelines Biosafety in Microbial and Biomedical Laboratories, 5th Edition 2007.

The USA PATRIOT Act of 2001 and the Bioterrorism Preparedness Act of 2002, requires under punishment by fine or imprisonment notification, strict handling and security procedures for possession, transportation or research work with Select Agents.

The University has adopted an Exposure Control Plan for compliance with OSHA's Bloodborne Pathogens Exposure Control Program standard. The Plan is administered by the Environmental Health & Safety Department and training for employees at risk is provided by Duquesne’s Health Services.